David Berman
Direttore Tecnico/Scientifico/R&S presso IMMUNOCORE HOLDINGS PLC
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di David Berman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | 01/01/2019 | - |
Storia della carriera di David Berman
Precedenti posizioni note di David Berman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2005 | 01/01/2015 |
Formazione di David Berman
| Massachusetts Institute of Technology | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 3 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Borsa valori
- Insiders
- David Berman
- Esperienza
